Reply by Authors

J Urol. 2024 Oct;212(4):548-549. doi: 10.1097/JU.0000000000004166. Epub 2024 Sep 10.

Cecilie Siggaard Jørgensen^{1

2}, Lien Dossche^{3

4}, Rongqun Zhai⁵, Michal Maternik⁶, Konstantinos Kamperis^{1

2

4}, Anders S Breinbjerg^{1

2}, Sevasti Karamaria³, Kristina Thorsteinsson⁷, Britt Borg^{1

2

8}, Yihe Wang⁵, Shuai Li⁵, Ann Raes^{3

4}, Lu Wei⁹, Aleksandra Żurowska⁶, Søren Hagstrøm⁷, Johan Vande Walle^{3

4}, Wen Jian Guo⁵, Søren Rittig^{1

2

4}

¹ Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.
² Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
³ Department of Pediatric Nephrology, Ghent University Hospital, Ghent, Belgium.
⁴ European Reference Network for Rare Kidney Diseases (ERKNet), Heidelberg, Germany.
⁵ Henan Joint International Pediatric Urodynamic Laboratory, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
⁶ Department of Pediatrics, Nephrology and Hypertension, Medical University of Gdansk, Gdansk, Poland.
⁷ Department of Paediatrics and Adolescent Medicine and Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark.
⁸ Research and Development, Therapeutic Area, Urology, Ferring Pharmaceuticals, Copenhagen, Denmark.
⁹ Department of Urology, Xinyang Central Hospital, Xinyang, China.

No abstract available

Publication types